Arrowhead Pharmaceuticals, Inc.

NasdaqGS:ARWR Stock Report

Market Cap: US$3.5b

Arrowhead Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ARWR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Mar 24BuyUS$82,990Hongbo LuIndividual3,000US$28.00
06 Mar 24SellUS$1,407,600Kenneth MyszkowskiIndividual40,000US$35.19
20 Nov 23SellUS$567,315Javier San MartinIndividual19,700US$29.00
28 Sep 23SellUS$40,812Victoria VakienerIndividual1,550US$26.33
03 Jul 23SellUS$315,142Tracie OliverIndividual8,925US$35.31
30 Jun 23SellUS$106,590James HamiltonIndividual3,000US$35.53
27 Jun 23SellUS$543,000Kenneth MyszkowskiIndividual15,000US$36.20
05 May 23SellUS$265,850Douglass GivenIndividual6,500US$40.90

Insider Trading Volume

Insider Buying: ARWR insiders have sold more shares than they have bought in the past 3 months.


Ownership Breakdown

What is the ownership structure of ARWR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies13,7930.0111%
State or Government57,5060.0464%
Individual Insiders4,885,1663.94%
General Public40,592,36132.8%
Institutions78,348,08863.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.4%.


Top Shareholders

Top 25 shareholders own 50.95% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.7%
BlackRock, Inc.
13,303,757US$371.0m3.62%0.01%
8.61%
The Vanguard Group, Inc.
10,672,076US$297.6m-1.72%no data
5.51%
State Street Global Advisors, Inc.
6,825,111US$190.4m16.4%0.01%
3%
Christopher Anzalone
3,715,048US$103.6m87.3%no data
2.72%
FMR LLC
3,370,637US$94.0m-21.8%0.01%
2.01%
JP Morgan Asset Management
2,485,323US$69.3m-7.05%0.01%
1.88%
Geode Capital Management, LLC
2,326,876US$64.9m4.9%0.01%
1.6%
Invesco Ltd.
1,982,426US$55.3m-9.4%0.01%
1.18%
UBS Asset Management AG
1,459,880US$40.7m31.5%0.01%
1.15%
Credit Suisse Asset Management (Switzerland) Ltd.
1,421,353US$39.6m17%0.03%
1.07%
Slate Path Capital LP
1,329,000US$37.1m0%0.76%
1.07%
Norges Bank Investment Management
1,321,927US$36.9m-11%no data
1.03%
Capital Research and Management Company
1,277,560US$35.6m55.3%no data
0.99%
Northern Trust Global Investments
1,229,615US$34.3m-2.92%0.01%
0.99%
Rokos Capital Management LLP
1,229,148US$34.3m-26.7%0.95%
0.91%
Avoro Capital Advisors LLC
1,130,000US$31.5m100%0.4%
0.83%
Artal Group S.A.
1,028,255US$28.7m18,800%0.72%
0.77%
BNY Mellon Asset Management
950,742US$26.5m-3.55%no data
0.75%
Columbia Management Investment Advisers, LLC
928,600US$25.9m33.9%0.01%
0.75%
Woodline Partners LP
927,187US$25.9m97.9%0.27%
0.73%
Aquilo Capital Management, LLC
908,474US$25.3m0%14.63%
0.72%
Goldman Sachs Group, Investment Banking and Securities Investments
888,915US$24.8m216%0.01%
0.68%
Charles Schwab Investment Management, Inc.
845,979US$23.6m0.12%no data
0.66%
Western Financial Corporation
820,239US$22.9m0%14.48%
0.6%
First Manhattan Co. LLC
743,721US$20.7m-32.3%0.06%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.